Correction to: Cell Death & Disease
https://doi.org/10.1038/s41419-020-02940-w published online 14 September 2020
Owing to an error in production, the original version of this Article contained an error in the author affiliations.
Author Francesca Pentimalli was incorrectly associated with Histopathological Unit, IRCCS-Istituto Tumori “Giovanni Paolo II”, Viale Orazio Flacco 65, 70124 Bari, Italy. The author’s actual affiliation is Cell Biology and Biotherapy Unit, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, I-80131 Napoli, Italy.
We apologise for this error, and confirm that it this has now been corrected in both the PDF and HTML versions of the Article.
Author information
Authors and Affiliations
Corresponding author
Additional information
Edited by G. Melino
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Costa, C., Indovina, P., Mattioli, E. et al. Correction: P53-regulated miR-320a targets PDL1 and is downregulated in malignant mesothelioma. Cell Death Dis 11, 867 (2020). https://doi.org/10.1038/s41419-020-03016-5
Published:
DOI: https://doi.org/10.1038/s41419-020-03016-5
This article is cited by
-
Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
Journal of Experimental & Clinical Cancer Research (2021)
